GlassScriptPhysician profile
Steven Larsen
NPI 1508953555
$1,046.01
in general payments reported to CMS, 2019-2025
8 companies · $651 in 2025
The $651 reported for 2025 was more than what 81% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.90 · 2021: $44.43 · 2023: $41.88 · 2024: $249 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $476 · Travel and Lodging: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.96 |
| Travel and Lodging | $465.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $521.32 | 2025 | Proclaim |
| Mml US, INC. | $232.06 | 2024-2025 | Reactiv8 |
| Lundbeck LLC | $151.68 | 2023-2025 | Vyepti |
| Lantheus Medical Imaging, INC. | $44.43 | 2021 | |
| Leica Microsystems INC. | $41.31 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.79 | 2025 | Caplyta |
| Turn-Key Medical, INC. | $18.59 | 2019 | |
| Dexcom, INC. | $16.83 | 2024 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Larsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.